Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
119.4 USD | -0.33% | -0.07% | -1.93% |
04-15 | Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept | MT |
04-04 | Zimmer Biomet Partners with Three Pickleball Organizations in US | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
Weaknesses
- The firm trades with high earnings multiples: 22.79 times its 2024 earnings per share.
- With an enterprise value anticipated at 3.67 times the sales for the current fiscal year, the company turns out to be overvalued.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.93% | 24.52B | B | ||
-2.31% | 187B | C+ | ||
-3.20% | 106B | C | ||
-5.04% | 66.9B | A | ||
+0.20% | 49.45B | B- | ||
+17.29% | 48B | B- | ||
+4.06% | 40.84B | B+ | ||
+2.07% | 26.48B | B | ||
+2.36% | 26.25B | A- | ||
+12.96% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ZBH Stock
- Ratings Zimmer Biomet Holdings, Inc.